Phase III Trial BI 695502 Plus Chemotherapy vs. Avastin® Plus Chemotherapy in Patients With Lung Cancer

NCT ID: NCT02272413

Last Updated: 2020-01-13

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE3

Total Enrollment

671 participants

Study Classification

INTERVENTIONAL

Study Start Date

2015-07-08

Study Completion Date

2018-11-16

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The objective of this phase III trial is to establish statistical equivalence in terms of efficacy (best overall response rate \[ORR\], proportion of patients with complete response \[CR\] plus partial response \[PR\]) until 18 weeks of first-line treatment with BI 695502 plus chemotherapy versus Avastin® plus chemotherapy followed by maintenance monotherapy with either BI 695502 or Avastin®.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Carcinoma, Non-Small-Cell Lung

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

BI 695502

Group Type EXPERIMENTAL

BI 695502

Intervention Type DRUG

Avastin

Group Type ACTIVE_COMPARATOR

Avastin

Intervention Type DRUG

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

BI 695502

Intervention Type DRUG

Avastin

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Adult patients aged \>=18 years with histologically or cytologically confirmed advanced nonsquamous non-small cell lung cancer (nsNSCLC). Mixed tumors should be categorized according to the predominant histology.

Note: NSCLC should be predominantly nonsquamous. Recurrent or metastatic disease (Stage IV) with an indication for therapy with paclitaxel + carboplatin + Avastin®.

Patients harboring tumors with unknown or without activating epidermal growth factor receptor (EGFR) / anaplastic lymphoma receptor tyrosine kinase (ALK) mutation maybe included provided chemotherapy is standard of care. At least one measurable lesion according to Response Evaluation Criteria in Solid Tumors (RECIST) 1.1 based on independent central review.

Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0 or 1.

Adequate hepatic, renal, and bone marrow function:

Exclusion Criteria

Prior therapy with monoclonal antibodies or small molecule inhibitors against Vascular Endothelial Growth Factor (VEGF) or VEGF receptors, including Avastin®.

Prior systemic therapy for metastatic disease. Prior systemic anticancer therapy or radiotherapy for locally advanced nsNSCLC if completed \<12 months prior to Screening.

Previous malignancy other than NSCLC in the last 5 years except for basal cell cancer of the skin or pre-invasive cancer of the cervix.

Symptomatic brain metastasis. Diagnosis of small cell carcinoma of the lung, squamous cell carcinoma of the lung, NSCLC not specified (NS) or NSCLC not otherwise specified(NOS).

Any unresolved toxicity \> Common Toxicity Criteria Grade 1 (except alopecia) from previous anticancer therapy (including radiotherapy).
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Boehringer Ingelheim

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Boehringer Ingelheim

Role: STUDY_CHAIR

Boehringer Ingelheim

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Pacific Cancer Medical Center, Inc.

Anaheim, California, United States

Site Status

Comprehensive Blood and Cancer Center

Bakersfield, California, United States

Site Status

Lalita Pandit, M.D., Inc.

Fountain Valley, California, United States

Site Status

Southern California Oncology Research Alliance

Los Angeles, California, United States

Site Status

Innovative Clinical Research, Inc.

Whittier, California, United States

Site Status

Ashland Bellefonte Cancer Center

Ashland, Kentucky, United States

Site Status

Reliant Medical Group

Worcester, Massachusetts, United States

Site Status

Detroit Clinical Research Center

Owosso, Michigan, United States

Site Status

Carolinas Cancer Care

Charlotte, North Carolina, United States

Site Status

CENIT - Centro de Neurociencias, Investigacion y Tratamiento

Ciudad Autonoma Buenos Aires, , Argentina

Site Status

Sanatorio Delta

Rosario, , Argentina

Site Status

Sanatorio Parque

Rosario, , Argentina

Site Status

Centro Oncológico de Rosario

Rosario, , Argentina

Site Status

CPCO - Centro de Pesquisa Clinica em Oncologia

Cachoeiro de Itapemirim, , Brazil

Site Status

Hospital do Cancer do Ceara

Fortaleza, , Brazil

Site Status

Pronutrir

Fortaleza, , Brazil

Site Status

Hospital de Carida de de Ijui - CACON

Ijuí, , Brazil

Site Status

Hospital Bruno Born

Lajeado, , Brazil

Site Status

Hospital da Cidade de Passo Fundo

Passo Fundo, , Brazil

Site Status

Universidade de Caxias do Sul - IPCEM - Inst. de Pesq.clilni

Petrópolis, , Brazil

Site Status

Irmandade da Santa Casa de Misericórdia de Porto Alegre

Porto Alegre, , Brazil

Site Status

Hospital de Clínicas de Porto Alegre

Porto Alegre, , Brazil

Site Status

CEPHO - Centro de Estudos e Pesquisas em Hematologia e Oncologia

Santo André, , Brazil

Site Status

ICAVC - Instituto do Cancer Arnaldo Vieira de Carvalho

São Paulo, , Brazil

Site Status

ICESP - Instituto do Cancer do Estado de Sao Paulo

São Paulo, , Brazil

Site Status

Clinica de Oncologia de Sorocaba

Sorocaba, , Brazil

Site Status

MHAT - Dobrich, AD

Dobrich, , Bulgaria

Site Status

UMHAT Georgi Stranski, Clinic of Paediatrics, Pleven

Pleven, , Bulgaria

Site Status

Complex Oncological Center - Plovdiv, EOOD

Plovdiv, , Bulgaria

Site Status

DCC 1 - Ruse, EOOD

Rousse, , Bulgaria

Site Status

MHAT Serdika, EOOD, Sofia

Sofia, , Bulgaria

Site Status

MHAT 'Tokuda Hospital Sofia', EAD

Sofia, , Bulgaria

Site Status

SHATOD 'Dr. Marko Antonov Markov'-Varna, EOOD

Varna, , Bulgaria

Site Status

Clínica Santa María

Santiago, , Chile

Site Status

Hospital Clínico San Borja Arriarán

Santiago, , Chile

Site Status

Centro Internacional de Estudios Clinicos - CIEC

Santiago, , Chile

Site Status

Instituto Clínico Oncológico del Sur - ICOS

Temuco, , Chile

Site Status

Hospital Clinico Viña del Mar

Viña del Mar, , Chile

Site Status

General Hospital Pula

Pula, , Croatia

Site Status

Clinical Hospital Centar Sestre Milosrdnice

Zagreb, , Croatia

Site Status

University Clinic for Pulmonary Diseases

Zagreb, , Croatia

Site Status

Oncology Centre- Mansoura University

Al Mansurah, , Egypt

Site Status

Alexandria University Hospital

Alexandria, , Egypt

Site Status

Ain Shams University Hospital

Cairo, , Egypt

Site Status

National Cancer Institute, Cairo University

Cairo, , Egypt

Site Status

Nasser Institute

Cairo, , Egypt

Site Status

Menofiya University Hospital

Monofia, , Egypt

Site Status

Gesundheitszentrum Wetterau gGmbH

Bad Nauheim, , Germany

Site Status

Athens Hospital of Chest Diseases "Sotiria"

Athens, , Greece

Site Status

University General Hospital of Heraklion

Crete, , Greece

Site Status

University of Patras Medical School

Pátrai, , Greece

Site Status

Euromedica Kyanous Stavros General Hospital

Thessaloniki, , Greece

Site Status

Health Center of Thermi, Thessaloniki

Thessaloniki, , Greece

Site Status

Interbalkan Medical Center of Thessaloniki

Thessaloniki, , Greece

Site Status

National Koranyi TBC and Pulm. Internal Med. Clinic

Budapest, , Hungary

Site Status

Semmelweis University

Budapest, , Hungary

Site Status

Pulmonology Institute of Veszprem County, Farkasgyepu

Farkasgyepű, , Hungary

Site Status

Jasz-Nagykun-Szolnok Megyei Hetenyi G. Korhaz-Rendelointezet

Szolnok, , Hungary

Site Status

Markusovszky University Teaching Hospital

Szombathely, , Hungary

Site Status

Tudogyogyintezet Torokbalint

Törökbálint, , Hungary

Site Status

ASST di Cremona

Cremona, , Italy

Site Status

Osp. Umberto I

Lugo (RA), , Italy

Site Status

Istituto Scientifico Romagnolo

Meldola (FC), , Italy

Site Status

Azienda Ospedaliera Universitaria Pisana

Pisa, , Italy

Site Status

Aichi Medical University Hospital

Aichi, Nagakute, , Japan

Site Status

Aichi Cancer Center Aichi Hospital

Aichi, Okazaki, , Japan

Site Status

Tosei General Hospital

Aichi, Seto, , Japan

Site Status

Fujita Health University Hospital

Aichi, Toyoake, , Japan

Site Status

Aso Co.,Ltd Iizuka Hospital

Fukuoka, Iizuka, , Japan

Site Status

Gunma Prefectural Cancer Center

Gunma, Ota, , Japan

Site Status

Hyogo Prefectural Amagasaki General Medical Center

Hyogo, Amagasaki, , Japan

Site Status

Itami City Hospital

Hyogo, Itami, , Japan

Site Status

Kobe City Medical Center General Hospital

Hyogo, Kobe, , Japan

Site Status

Ibaraki Prefectural Central Hospital

Ibaraki, Kasama, , Japan

Site Status

Kagawa Rosai Hospital

Kagawa, Marugame, , Japan

Site Status

Kitasato University Hospital

Kanagawa, Sagamihara, , Japan

Site Status

Yokohama City University Hospital

Kanagawa, Yokohama, , Japan

Site Status

Uji-Tokushukai Medical Center

Kyoto, Uji, , Japan

Site Status

Matsusaka City Hospital

Mie, Matsusaka, , Japan

Site Status

Miyazaki Prefectural Miyazaki Hospital

Miyazaki, Miyazaki, , Japan

Site Status

Nara Hospital Kinki University Faculty of Medicine

Nara, Ikoma, , Japan

Site Status

Niigata Cancer Center Hospital

Niigata, Niigata, , Japan

Site Status

Kansai Medical University Hospital

Osaka, Hirakata, , Japan

Site Status

Osaka Medical Center for Cancer and Cardiovascular Diseases

Osaka, Osaka, , Japan

Site Status

Takatsuki Red Cross Hospital

Osaka, Takatsuki, , Japan

Site Status

Saitama Medical University International Medical Center

Saitama, Hidaka, , Japan

Site Status

National Hospital Organization Kinki-Chuo Chest Medical Center

Sakaishi, , Japan

Site Status

Nippon Medical School Hospital

Tokyo, Bunkyo-ku, , Japan

Site Status

Nihon University Itabashi Hospital

Tokyo, Itabashi-ku, , Japan

Site Status

Japan Anti-Tuberculosis Association Fukujuji Hospital

Tokyo, Kiyose, , Japan

Site Status

Toranomon Hospital

Tokyo, Minato-ku, , Japan

Site Status

Hospital Pulau Pinang

Georgetown Pulau Pinang, , Malaysia

Site Status

University Malaya Medical Centre

Kuala Lumpur, , Malaysia

Site Status

Hospital Tengku Ampuan Afzan

Kuantan, , Malaysia

Site Status

Investigacion Biomedica para el Desarrollo de Farmacos

El Salto, , Mexico

Site Status

Unidad de Atencion Medica e Investigacion en Salud S.C.

Mérida, , Mexico

Site Status

Axis Heilsa S. de R.L. de C.V., Monterrey

Monterrey, , Mexico

Site Status

Clinical Medical Research S.C

Orizaba, , Mexico

Site Status

Hospital San Jose Querétaro

Querétaro, , Mexico

Site Status

Centro Hemato Oncológico Privado

Toluca, , Mexico

Site Status

Dr. Pablo O. Torre Memorial Hospital

Bacolod City, , Philippines

Site Status

Cebu Doctors Hospital

Cebu City, , Philippines

Site Status

Perpetual Succour Hospital (Cebu)

Cebu City, , Philippines

Site Status

Manila Doctors Hospital

Manila, , Philippines

Site Status

Lung Center of the Philippines

Quezon City, , Philippines

Site Status

Wojewodzkie Centrum Szpitalne Kotliny Jeleniogorskiej

Jelenia Góra, , Poland

Site Status

KO-MED Centra Kliniczne Lublin II

Lublin, , Poland

Site Status

Zofia Tarnowska domo Zamoyska,RegHosp.Cardiol.Dep,Tarnobrzeg

Tarnobrzeg, , Poland

Site Status

The Provincial Polyclinical Hospital in Torun

Torun, , Poland

Site Status

Onco.Cent. - Instit. of Maria Sklodowskiej-Curie

Warsaw, , Poland

Site Status

Magodent Sp. Z o.o.

Warsaw, , Poland

Site Status

CHUC - Centro Hospitalar e Universitário de Coimbra, EPE

Coimbra, , Portugal

Site Status

Centro Hospitalar Lisboa Norte Hospital Pulido Valente

Lisbon, , Portugal

Site Status

IPO Porto Francisco Gentil, EPE

Porto, , Portugal

Site Status

Centro Hospitalar de Entre o Douro e Vouga, E.P.E. - Hospital de São Sebastião

Santa Maria da Feira, , Portugal

Site Status

Centro Hospitalar de Vila Nova de Gaia

Vila Nova de Gaia, , Portugal

Site Status

Baia Mare Emergency County Hospital

Baia Mare, , Romania

Site Status

Institute of Oncology 'Prof. Dr. Alexandru Trestioreanu'

Bucharest, , Romania

Site Status

Spitalul Militar de Urgenta Dr.Papilian, Cluj-Napoca

Cluj-Napoca, , Romania

Site Status

Spitalul Clinic Judetean de Urgenta Cluj Napoca

Cluj-Napoca, , Romania

Site Status

S.C Oncocenter Oncologie Clinica S.R.L

Timișoara, , Romania

Site Status

SBIH of Arkhangelsk reg. "Arkhangelsk Clin. Onc. Dispensary"

Arkhangelsk, , Russia

Site Status

St.Auton.Heal.Inst."Rep.Clin.Onc.Disp.of MoH of Rep. Tatarstan"

Kazan', , Russia

Site Status

RBIH "Kursk regional clinical oncology dispensary"

Kursk, , Russia

Site Status

FSBI "N.N Blokhin Med.Res.Cent.Onc."MoH of RF

Moscow, , Russia

Site Status

BHI of Omsk region - Clinical Oncology Dispensary

Omsk, , Russia

Site Status

SBIH of Stavropol territory "Pyatigorsk Oncol. Dispensary"

Pyatigorsk, , Russia

Site Status

GUZ Leningradskaya Regional Clin. Hospital, St. Petersburg

Saint Petersburg, , Russia

Site Status

1stPavlov St.Med.Univ.St.-Petersburg Res.Inst.

Saint Petersburg, , Russia

Site Status

SPb SBIH "City Clinical Oncological Dispensary"

Saint Petersburg, , Russia

Site Status

FSBI "N.N. Petrov National Medical Research Center of Oncology" of MoH of RF

Saint Petersburg, , Russia

Site Status

Institute for Oncol & Radiol of Serbia, Clinic f. Med. Onco.

Belgrade, , Serbia

Site Status

Clinical Center Bezanijska kosa, Belgrade

Belgrade, , Serbia

Site Status

Clinic of Pulmonary Diseases and Tuberculosis 'Knez Selo'

Gornji Matejevac, , Serbia

Site Status

Inst. for Pulm. Diseases of Vojvodine, Clinic f. Pulm. Oncol

Kamenitz, , Serbia

Site Status

Clinical Center Kragujevac

Kragujevac, , Serbia

Site Status

GVI Cape Gate Oncology Centre

Cape Town, , South Africa

Site Status

Rondebosch Oncology Centre

Cape Town, , South Africa

Site Status

GVI Oncology Outeniqua Unit

George, , South Africa

Site Status

West Rand Oncology Centre, Johannesburg

Johannesburg, , South Africa

Site Status

Langenhoven Drive Oncology Centre

Port Elizabeth, , South Africa

Site Status

Chungbuk National University Hospital

Cheongju-si, , South Korea

Site Status

Chonnam National University Hwasun Hospital

Hwasun-gun, , South Korea

Site Status

Gachon University Gil Medical Center

Incheon, , South Korea

Site Status

Asan Medical Center

Seoul, , South Korea

Site Status

Korea University Guro Hospital

Seoul, , South Korea

Site Status

The Catholic University of Korea, St.Vincent's Hospital

Suwon, , South Korea

Site Status

Hospital Infanta Cristina

Badajoz, , Spain

Site Status

Hospital General Universitario Gregorio Marañón

Madrid, , Spain

Site Status

Hospital La Paz

Madrid, , Spain

Site Status

Hospital Clínico de Santiago

Santiago de Compostela, , Spain

Site Status

Hospital Virgen del Rocío

Seville, , Spain

Site Status

Hospital Nuestra Señora de Valme

Seville, , Spain

Site Status

Instituto Valenciano de Oncología

Valencia, , Spain

Site Status

Hospital Miguel Servet

Zaragoza, , Spain

Site Status

Songklanagarind Hospital

Hat Yai, , Thailand

Site Status

Ubonratchathani Cancer Hospital, Muang

Muang, , Thailand

Site Status

Udonthani Cancer Hospital, Muang

Muang, , Thailand

Site Status

Maharaj Nakorn Chiang Mai Hospital

Muang, , Thailand

Site Status

Lampang Hospital

Muang, , Thailand

Site Status

Naresuan University Hospital

Muang, , Thailand

Site Status

Akdeniz University Medical Faculty

Antalya, , Turkey (Türkiye)

Site Status

Inonu Uni. Med. Fac., Battalgazi

Battalgazi, , Turkey (Türkiye)

Site Status

Dicle University Medical Faculty

Diyarbakır, , Turkey (Türkiye)

Site Status

Trakya Universitesi Tip Fakultesi

Edirne, , Turkey (Türkiye)

Site Status

Gaziantep University

Gaziantep, , Turkey (Türkiye)

Site Status

Bezmi Alem Foundation University Medical Faculty Hospital

Istanbul, , Turkey (Türkiye)

Site Status

Yeditepe University Medical School Hospital

Istanbul, , Turkey (Türkiye)

Site Status

Fatih University Faculty of Medicince, Istanbul

Istanbul, , Turkey (Türkiye)

Site Status

CTPI Chernihiv Regional Oncological Dispensary, Chernihiv

Chernihiv, , Ukraine

Site Status

Munic.Instit."City Clin.Hosp.#4" of Dnipro City Council

Dnipropetrovsk, , Ukraine

Site Status

CHI Kharkiv Regional Clinical Oncological Center

Kharkiv, , Ukraine

Site Status

Kherson Regional Oncologic Dispensary, Kherson

Kherson, , Ukraine

Site Status

Treatment-Diagnostic CTR of Private Enterprise, Kirovohrad

Kirovohrad, , Ukraine

Site Status

CI Kryvyi Rih Oncological Dispensary of DRC

Kryvyi Rih, Dnipropetrovsk, , Ukraine

Site Status

National Institute of Cancer

Kyiv, , Ukraine

Site Status

Medical and Preventive Treatment Inst. Volyn Regional, Lutsk

Lutsk, , Ukraine

Site Status

CI of LRC Lviv Onco.Reg.Treat.&Diag.Cent.

Lviv, , Ukraine

Site Status

Poltava Regional Clinical Oncological Dispensary, Poltava

Poltava, , Ukraine

Site Status

Sumy Regional Oncology Center

Sumy, , Ukraine

Site Status

CI of TRC Ternopil RC Oncological Dispensary Thoracic Dept

Ternopil, , Ukraine

Site Status

Uzhgorod National University, Oncology Centre

Uzhhorod, , Ukraine

Site Status

Transcarpathian Reg Clin Oncological Dispensary, Uzhgorod

Uzhhorod, , Ukraine

Site Status

Vinnytsia Regional Clinical Oncological Dispensary

Vinnytsia, , Ukraine

Site Status

CI Zapor Reg Cl Oncological Dispensary of ZRC, Zhaporizhzhia

Zhaporizhzhia, , Ukraine

Site Status

Cheltenham General Hospital

Cheltenham, , United Kingdom

Site Status

Wythenshawe Hospital

Manchester, , United Kingdom

Site Status

Can Tho Oncology Hospital

Can Tho, , Vietnam

Site Status

Bach Mai hospital

Hanoi, , Vietnam

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States Argentina Brazil Bulgaria Chile Croatia Egypt Germany Greece Hungary Italy Japan Malaysia Mexico Philippines Poland Portugal Romania Russia Serbia South Africa South Korea Spain Thailand Turkey (Türkiye) Ukraine United Kingdom Vietnam

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol

View Document

Document Type: Statistical Analysis Plan

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2014-002161-30

Identifier Type: EUDRACT_NUMBER

Identifier Source: secondary_id

1302.5

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.